Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionBrookstone Capital Management
Latest Disclosed Ownership103,662 shares
Latest Disclosed Value $ 14,447,402
Brookstone Capital Management reports 10.15% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 16, 2026 - Brookstone Capital Management filed a 13F-HR form disclosing ownership of 103,662 shares of Gilead Sciences, Inc. (CH:GILD) valued at $14,447,402 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 115,370 shares of Gilead Sciences, Inc.. This represents a change in shares of -10.15% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F GILEAD SCIENCES COM 375558103 103,662 -11,708 -10.15 14,447 2.03 0.1651
2026-01-15 2025-12-31 13F GILEAD SCIENCES COM 375558103 115,370 -5,279 -4.38 14,160 5.73 0.1620
2025-10-15 2025-09-30 13F GILEAD SCIENCES COM 375558103 120,649 -2,639 -2.14 13,392 -2.02 0.1598
2025-07-30 2025-06-30 13F GILEAD SCIENCES COM 375558103 123,288 3,848 3.22 13,669 2.13 0.1793
2025-04-29 2025-03-31 13F GILEAD SCIENCES COM 375558103 119,440 -28,012 -19.00 13,383 -1.74 0.1918
2025-01-13 2024-12-31 13F GILEAD SCIENCES COM 375558103 147,452 600 0.41 13,620 10.62 0.1982
2024-10-08 2024-09-30 13F GILEAD SCIENCES COM 375558103 146,852 992 0.68 12,312 15.16 0.1815
2024-07-18 2024-06-30 13F GILEAD SCIENCES COM 375558103 145,860 18,602 14.62 10,692 14.70 0.1774
2024-04-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 127,258 112,305 751.05 9,322 669.69 0.1666
2024-01-11 2023-12-31 13F GILEAD SCIENCES COM 375558103 14,953 406 2.79 1,211 6.13 0.0236
2023-10-20 2023-09-30 13F GILEAD SCIENCES COM 375558103 14,547 1,390 10.56 1,141 16.55 0.0250
2023-07-11 2023-06-30 13F GILEAD SCIENCES COM 375558103 13,157 625 4.99 979 -6.58 0.0197
2023-04-19 2023-03-31 13F GILEAD SCIENCES COM 375558103 12,532 -2,415 -16.16 1,048 -20.36 0.0204
2023-01-09 2022-12-31 13F GILEAD SCIENCES COM 375558103 14,947 -154,213 -91.16 1,317 -88.10 0.0266
2022-10-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 169,160 9,145 5.72 11,061 10.00 0.2557
2022-07-11 2022-06-30 13F GILEAD SCIENCES COM 375558103 160,015 55,379 52.93 10,055 55.27 0.2225
2022-04-12 2022-03-31 13F GILEAD SCIENCES COM 375558103 104,636 28,881 38.12 6,476 19.97 0.1267
2022-01-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 75,755 -439 -0.58 5,398 4.75 0.0930
2021-11-03 2021-09-30 13F GILEAD SCIENCES COM 375558103 76,194 12,760 20.12 5,153 19.45 0.0927
2021-07-14 2021-06-30 13F GILEAD SCIENCES COM 375558103 63,434 12,518 24.59 4,314 31.08 0.0773
2021-04-16 2021-03-31 13F GILEAD SCIENCES COM 375558103 50,916 -959 -1.85 3,291 8.90 0.1261
2021-01-13 2020-12-31 13F GILEAD SCIENCES COM 375558103 51,875 6,875 15.28 3,022 6.26 0.1201
2020-10-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 45,000 13,514 42.92 2,844 17.38 0.1314
2020-07-21 2020-06-30 13F GILEAD SCIENCES COM 375558103 31,486 -7,651 -19.55 2,423 -17.19 0.1510
2020-04-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 39,137 39,137 2,926 0.1683
2020-01-29 2019-12-31 13F GILEAD SCIENCES COM 375558103 0 -18,048 -100.00 0 -100.00
2019-10-18 2019-09-30 13F GILEAD SCIENCES COM 375558103 18,048 -16,456 -47.69 1,144 -50.92 0.0621
2019-07-25 2019-06-30 13F GILEAD SCIENCES COM 375558103 34,504 34,504 2,331 0.1347
2019-02-05 2018-12-31 13F GILEAD SCIENCES COM 375558103 0 -63,479 -100.00 0 -100.00
2018-11-05 2018-09-30 13F GILEAD SCIENCES COM 375558103 63,479 -6,727 -9.58 4,901 -1.45 0.3728
2018-08-06 2018-06-30 13F GILEAD SCIENCES COM 375558103 70,206 -2,348 -3.24 4,973 -9.09 0.4332
2018-04-23 2018-03-31 13F GILEAD SCIENCES COM 375558103 72,554 1,826 2.58 5,470 7.95 0.4964
2018-02-07 2017-12-31 13F GILEAD SCIENCES COM 375558103 70,728 70,728 5,067 0.4550
2016-04-14 2016-03-31 13F GILEAD SCIENCES INC COM COM 375558103 0 0 0 0.0000
2016-01-14 2015-12-31 13F GILEAD SCIENCES INC COM COM 375558103 0 -827 -100.00 0 -100.00
2015-10-28 2015-09-30 13F GILEAD SCIENCES INC COM COM 375558103 827 -494 -37.40 81 -47.74 0.0147
2015-08-11 2015-06-30 13F GILEAD SCIENCES INC COM COM 375558103 1,321 1,321 155 0.0195
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.